Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocol

INTRODUCTION: Secondary prevention drugs for cardiac disease have been demonstrated by clinical trials to be effective in reducing future cardiovascular and mortality events (WAMACH is the Western Australian Medication Adherence and Costs in Heart disease study). Hence, most countries have adopted h...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunnell, Anthony S, Knuiman, Matthew W, Geelhoed, Elizabeth, Hobbs, Michael S T, Katzenellenbogen, Judith M, Hung, Joseph, Rankin, Jamie M, Nedkoff, Lee, Briffa, Thomas G, Ortiz, Michael, Gillies, Malcolm, Cordingley, Anne, Messer, Mitch, Gardner, Christian, Lopez, Derrick, Atkins, Emily, Mai, Qun, Sanfilippo, Frank M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170208/
https://www.ncbi.nlm.nih.gov/pubmed/25234510
http://dx.doi.org/10.1136/bmjopen-2014-006258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170208/
https://www.ncbi.nlm.nih.gov/pubmed/25234510
http://dx.doi.org/10.1136/bmjopen-2014-006258

Ejemplares similares